Subclassification of Phenotypic Homozygous Familial Hypercholesterolemia

Area of Science:

• Cardiovascular Genetics
• Metabolic Disorders
• Clinical Lipidology

Background:

• Familial hypercholesterolemia (FH) encompasses a range of genetic conditions affecting LDL cholesterol metabolism.
• Homozygous familial hypercholesterolemia (HoFH) is characterized by extreme LDL cholesterol elevation due to biallelic genetic defects.
• Phenotypic variability exists, with some FH patients presenting intermediate severity between heterozygous FH and HoFH, recently termed 'severe FH'.

Purpose of the Study:

• To propose a refined classification system for patients with phenotypic HoFH.
• To differentiate between severe heterozygous FH, typical HoFH, and severe HoFH.
• To aid in tailoring treatment strategies based on disease severity and complications.

Main Methods:

• Analysis of LDL cholesterol levels.
• Evaluation of genetic backgrounds and residual LDL receptor activity.
• Assessment of clinical phenotypes and associated complications.

Main Results:

• Identification of three distinct phenotypic groups: severe heterozygous FH, typical HoFH, and severe HoFH.
• Establishment of criteria based on LDL-C, genetics, and complications for classification.
• Recognition of the need for phenotype-based stratification for effective management.

Conclusions:

• A proposed three-tiered classification system for phenotypic HoFH offers a more precise approach to patient stratification.
• This reclassification facilitates personalized treatment strategies for FH patients.
• Further research and clinical validation are warranted to implement this refined classification.